Christina Montag
Overview
Explore the profile of Christina Montag including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
193
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weekes M, Tan S, Poole E, Talbot S, Antrobus R, Smith D, et al.
Science
. 2013 Apr;
340(6129):199-202.
PMID: 23580527
The reactivation of latent human cytomegalovirus (HCMV) infection after transplantation is associated with high morbidity and mortality. In vivo, myeloid cells and their progenitors are an important site of HCMV...
2.
Montag C, Wagner J, Gruska I, Vetter B, Wiebusch L, Hagemeier C
J Virol
. 2011 Sep;
85(21):11409-21.
PMID: 21880774
Many viruses antagonize tumor necrosis factor alpha (TNF-α) signaling in order to counteract its antiviral properties. One way viruses achieve this goal is to reduce TNF-α receptor 1 (TNFR1) on...
3.
Montag C, Wagner J, Gruska I, Hagemeier C
J Virol
. 2006 Sep;
80(23):11686-98.
PMID: 17005669
NF-kappaB plays an important role in the early cellular response to pathogens by activating genes involved in inflammation, immune response, and cell proliferation and survival. NF-kappaB is also utilized by...
4.
Mlynarczuk-Bialy I, Roeckmann H, Kuckelkorn U, Schmidt B, Umbreen S, Golab J, et al.
Cancer Res
. 2006 Aug;
66(15):7598-605.
PMID: 16885359
Resistance of tumor cells to cisplatin is a common feature frequently encountered during chemotherapy against melanoma caused by various known and unknown mechanisms. To overcome drug resistance toward cisplatin, a...